5th Edition of International Heart Congress
June 24-26, 2027 | Hybrid Event
Cardiac Holter Monitoring
Cardiac Holter Monitoring is a non-invasive diagnostic technique designed to track and record the electrical activity of the heart over an extended period, typically 24 to 48 hours. Named after its inventor, Dr. Norman J. Holter, this method involves the use of a portable device called a Holter monitor, which continuously records the heart's rhythm, detecting irregularities that may not be evident during a brief office visit. This monitoring is particularly valuable for identifying sporadic cardiac issues such as arrhythmias, palpitations, and other abnormalities. By providing a comprehensive view of the heart's electrical patterns during daily activities, Cardiac Holter Monitoring assists healthcare professionals in formulating accurate diagnoses and tailoring treatment plans to enhance patient cardiac health.
John R Doty
Intermountain Medical Center, United States
Agustin Joison
Cordoba Catholic University, Argentina
Thomas J Webster
Brown University, United States
Uwe Peter Tigor
Auxilius Pharma, United States
Sergey Suchkov
N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Bijoy Krishna Banik
National Institute of Pharmaceutical Education and Research (NIPER)-Guwahati, IndiaSubmit your abstract Today
Title : Healing a broken heart: One nano beat at a time
Thomas J Webster, Brown University, United States
Title : Revolutionizing heart health through Personalized & Precision Medicine (PPM): Towards personalized cardiovascular prevention, precision cardiac care & rehabilitation via optimizing Cardiac Hospital Networks
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Antibody-proteases as unique biomarkers, potential targets and translational tools of the next step generation to be used in personalized and precision cardiology practice
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Investigation of bergapten’s pharmacological activity against doxorubicin induced cardiotoxicity: supporting evidence from cellular and animal models
Bijoy Krishna Banik, National Institute of Pharmaceutical Education and Research (NIPER)-Guwahati, India
Title : Frequency of residual risk in cardiovascular secondary prevention in patients treated at the Reina Fabiola University Clinic
Agustin Joison, Cordoba Catholic University, Argentina
Title : Antidiabetic agents – From treating diabetes to providing positive cardiovascular outcome
Syed Raza, Awali Hospital, Bahrain